Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucin-1 | 17 | 2023 | 544 | 2.810 |
Why?
|
Vimentin | 3 | 2018 | 261 | 1.140 |
Why?
|
Breast Neoplasms | 30 | 2023 | 20817 | 0.890 |
Why?
|
Carcinoma, Ductal, Breast | 6 | 2018 | 1101 | 0.700 |
Why?
|
Receptor, erbB-2 | 12 | 2021 | 2416 | 0.600 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 6 | 2014 | 345 | 0.570 |
Why?
|
Neoplastic Stem Cells | 8 | 2022 | 1376 | 0.540 |
Why?
|
Interferon-gamma | 2 | 2022 | 3203 | 0.530 |
Why?
|
Cadherins | 2 | 2018 | 907 | 0.470 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2022 | 8426 | 0.420 |
Why?
|
Neuroendocrine Cells | 2 | 2022 | 61 | 0.400 |
Why?
|
BRCA1 Protein | 2 | 2015 | 1149 | 0.390 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 4 | 2016 | 170 | 0.380 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2022 | 635 | 0.370 |
Why?
|
Transcription Factors | 8 | 2023 | 12207 | 0.360 |
Why?
|
Receptors, Progesterone | 9 | 2015 | 1097 | 0.350 |
Why?
|
Receptors, Estrogen | 9 | 2015 | 2186 | 0.330 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9438 | 0.320 |
Why?
|
Antigens, CD | 1 | 2018 | 4026 | 0.300 |
Why?
|
Immunohistochemistry | 12 | 2021 | 11368 | 0.290 |
Why?
|
Cell Line, Tumor | 12 | 2023 | 16687 | 0.280 |
Why?
|
Loss of Heterozygosity | 3 | 2015 | 684 | 0.280 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2020 | 332 | 0.270 |
Why?
|
Leukemia, Myeloid | 2 | 2005 | 705 | 0.260 |
Why?
|
Epigenesis, Genetic | 3 | 2023 | 3646 | 0.250 |
Why?
|
GATA3 Transcription Factor | 2 | 2016 | 157 | 0.250 |
Why?
|
Lymphatic Metastasis | 7 | 2018 | 2914 | 0.240 |
Why?
|
Colorectal Neoplasms | 6 | 2023 | 6773 | 0.240 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2017 | 9230 | 0.240 |
Why?
|
Acrylamides | 1 | 2023 | 255 | 0.200 |
Why?
|
Prognosis | 20 | 2020 | 29050 | 0.200 |
Why?
|
Aromatase Inhibitors | 3 | 2016 | 491 | 0.200 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2017 | 601 | 0.200 |
Why?
|
DNA Methylation | 2 | 2015 | 4289 | 0.200 |
Why?
|
Kaplan-Meier Estimate | 6 | 2018 | 6535 | 0.200 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3584 | 0.190 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2021 | 68 | 0.190 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2023 | 2041 | 0.180 |
Why?
|
STAT1 Transcription Factor | 1 | 2021 | 320 | 0.170 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3703 | 0.170 |
Why?
|
Interferons | 1 | 2023 | 706 | 0.170 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2021 | 736 | 0.170 |
Why?
|
Neoplasm Invasiveness | 4 | 2017 | 3614 | 0.170 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 113 | 0.170 |
Why?
|
Tamoxifen | 2 | 2013 | 981 | 0.170 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 4 | 2014 | 56 | 0.160 |
Why?
|
Video Recording | 1 | 2023 | 947 | 0.160 |
Why?
|
Humans | 66 | 2023 | 744220 | 0.160 |
Why?
|
Exosomes | 1 | 2023 | 413 | 0.160 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2022 | 300 | 0.160 |
Why?
|
Leukemia | 3 | 2014 | 1508 | 0.160 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2022 | 388 | 0.150 |
Why?
|
Pneumonectomy | 2 | 2017 | 1094 | 0.150 |
Why?
|
Wound Closure Techniques | 1 | 2018 | 83 | 0.150 |
Why?
|
Spores, Bacterial | 1 | 2017 | 118 | 0.150 |
Why?
|
DNA-Binding Proteins | 6 | 2023 | 9647 | 0.150 |
Why?
|
Female | 42 | 2023 | 380197 | 0.150 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2020 | 11493 | 0.140 |
Why?
|
Metaplasia | 1 | 2017 | 313 | 0.140 |
Why?
|
Japan | 6 | 2020 | 1361 | 0.140 |
Why?
|
Lung Neoplasms | 4 | 2023 | 13096 | 0.140 |
Why?
|
Phyllodes Tumor | 1 | 2016 | 53 | 0.140 |
Why?
|
Esophageal Neoplasms | 3 | 2019 | 1582 | 0.140 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2016 | 298 | 0.130 |
Why?
|
Axilla | 1 | 2018 | 595 | 0.130 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2187 | 0.130 |
Why?
|
Microsatellite Instability | 2 | 2016 | 684 | 0.130 |
Why?
|
Information Dissemination | 1 | 2023 | 1100 | 0.130 |
Why?
|
Indoles | 1 | 2023 | 1838 | 0.130 |
Why?
|
Retroviridae | 3 | 2007 | 914 | 0.130 |
Why?
|
Menstrual Cycle | 1 | 2018 | 551 | 0.130 |
Why?
|
Stomach Neoplasms | 3 | 2019 | 1333 | 0.130 |
Why?
|
NF-kappa B | 1 | 2023 | 2501 | 0.120 |
Why?
|
Cytidine Deaminase | 1 | 2016 | 252 | 0.120 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2014 | 46 | 0.120 |
Why?
|
Bacillus subtilis | 1 | 2017 | 359 | 0.120 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5221 | 0.120 |
Why?
|
Neoplasm Staging | 8 | 2017 | 11007 | 0.120 |
Why?
|
Multiprotein Complexes | 1 | 2020 | 1119 | 0.120 |
Why?
|
Prostatic Neoplasms | 4 | 2021 | 11074 | 0.120 |
Why?
|
Chromatin | 2 | 2023 | 2934 | 0.120 |
Why?
|
Digestive System Surgical Procedures | 1 | 2019 | 576 | 0.120 |
Why?
|
Middle Aged | 29 | 2020 | 213367 | 0.120 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 431 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1660 | 0.110 |
Why?
|
Carbon Dioxide | 1 | 2017 | 1147 | 0.110 |
Why?
|
Esophagectomy | 2 | 2014 | 447 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 1240 | 0.110 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2013 | 129 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 924 | 0.110 |
Why?
|
DNA Damage | 1 | 2023 | 2432 | 0.110 |
Why?
|
Immune System | 1 | 2018 | 805 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2013 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 3 | 2010 | 3385 | 0.110 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2012 | 95 | 0.110 |
Why?
|
Promoter Regions, Genetic | 4 | 2021 | 5867 | 0.110 |
Why?
|
Signal Transduction | 8 | 2023 | 23404 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2022 | 6352 | 0.100 |
Why?
|
Enhancer Elements, Genetic | 2 | 2010 | 1341 | 0.100 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1518 | 0.100 |
Why?
|
Lymph Node Excision | 1 | 2018 | 1256 | 0.100 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 164 | 0.100 |
Why?
|
Fanconi Anemia | 1 | 2014 | 319 | 0.100 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 2012 | 100 | 0.100 |
Why?
|
Laryngectomy | 1 | 2014 | 248 | 0.100 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.100 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2012 | 154 | 0.100 |
Why?
|
Pyrimidines | 1 | 2023 | 2940 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 989 | 0.100 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2727 | 0.100 |
Why?
|
Neuronal Plasticity | 1 | 2020 | 1422 | 0.100 |
Why?
|
Disease-Free Survival | 7 | 2016 | 6893 | 0.100 |
Why?
|
Pharynx | 1 | 2014 | 413 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2022 | 1634 | 0.100 |
Why?
|
Hemangioblasts | 1 | 2010 | 28 | 0.090 |
Why?
|
Femur Neck | 1 | 2012 | 309 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2016 | 13036 | 0.090 |
Why?
|
Proportional Hazards Models | 5 | 2016 | 12355 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.090 |
Why?
|
Ganglia, Spinal | 2 | 2003 | 519 | 0.090 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 4033 | 0.090 |
Why?
|
Cell Adhesion Molecules | 2 | 2013 | 1602 | 0.090 |
Why?
|
Head and Neck Neoplasms | 2 | 2014 | 2732 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1061 | 0.090 |
Why?
|
RNA-Binding Proteins | 2 | 2016 | 1903 | 0.090 |
Why?
|
Premenopause | 1 | 2013 | 1033 | 0.090 |
Why?
|
Glutamine | 1 | 2012 | 578 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4553 | 0.090 |
Why?
|
Mastectomy | 1 | 2017 | 1793 | 0.080 |
Why?
|
Nuclear Proteins | 3 | 2020 | 5853 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2014 | 783 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 21672 | 0.080 |
Why?
|
Mutation | 5 | 2023 | 29784 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 640 | 0.080 |
Why?
|
Hernia | 1 | 2008 | 71 | 0.080 |
Why?
|
Sciatic Neuropathy | 1 | 2008 | 74 | 0.080 |
Why?
|
Ki-67 Antigen | 3 | 2015 | 644 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2072 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4752 | 0.080 |
Why?
|
Echinococcus granulosus | 1 | 2007 | 10 | 0.080 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2013 | 1187 | 0.070 |
Why?
|
Echinococcosis, Hepatic | 1 | 2007 | 24 | 0.070 |
Why?
|
Fluorouracil | 1 | 2012 | 1616 | 0.070 |
Why?
|
Leukemia, Experimental | 1 | 2007 | 246 | 0.070 |
Why?
|
Receptors, Androgen | 1 | 2013 | 1057 | 0.070 |
Why?
|
Adult | 15 | 2020 | 214035 | 0.070 |
Why?
|
Terminal Repeat Sequences | 1 | 2007 | 72 | 0.070 |
Why?
|
Aged | 15 | 2020 | 163253 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2013 | 933 | 0.070 |
Why?
|
Retroviridae Infections | 1 | 2007 | 151 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3469 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3669 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2009 | 2942 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7281 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2012 | 1782 | 0.070 |
Why?
|
Inflammation | 2 | 2023 | 10634 | 0.070 |
Why?
|
Carcinoma | 1 | 2017 | 2375 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2013 | 5974 | 0.070 |
Why?
|
Gene Dosage | 2 | 2012 | 1251 | 0.070 |
Why?
|
Colony-Forming Units Assay | 1 | 2005 | 354 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19907 | 0.070 |
Why?
|
DNA Repair | 1 | 2014 | 2046 | 0.060 |
Why?
|
Pleural Neoplasms | 1 | 2009 | 607 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2020 | 57768 | 0.060 |
Why?
|
Genes, ras | 1 | 2007 | 690 | 0.060 |
Why?
|
Axons | 2 | 2003 | 1686 | 0.060 |
Why?
|
Mice | 14 | 2022 | 81178 | 0.060 |
Why?
|
Intestinal Obstruction | 1 | 2008 | 424 | 0.060 |
Why?
|
Mice, Nude | 2 | 2022 | 3689 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5257 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2023 | 35 | 0.060 |
Why?
|
Osteosarcoma | 1 | 2009 | 881 | 0.060 |
Why?
|
Tumor Virus Infections | 1 | 2007 | 452 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2944 | 0.060 |
Why?
|
Emigration and Immigration | 1 | 2007 | 404 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2948 | 0.060 |
Why?
|
Receptor, trkC | 1 | 2003 | 68 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13280 | 0.060 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2023 | 91 | 0.050 |
Why?
|
Mutagenesis, Insertional | 1 | 2005 | 655 | 0.050 |
Why?
|
Ligands | 2 | 2023 | 3294 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1827 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2020 | 4201 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5670 | 0.050 |
Why?
|
Animals | 17 | 2022 | 168788 | 0.050 |
Why?
|
Sequence Deletion | 1 | 2007 | 1526 | 0.050 |
Why?
|
HCT116 Cells | 2 | 2014 | 408 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6172 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11478 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2023 | 317 | 0.050 |
Why?
|
Receptors, Interferon | 1 | 2022 | 115 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2005 | 774 | 0.050 |
Why?
|
Proprioception | 1 | 2002 | 132 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2012 | 2915 | 0.050 |
Why?
|
Treatment Outcome | 10 | 2019 | 63119 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2023 | 2503 | 0.050 |
Why?
|
Down-Regulation | 2 | 2019 | 3001 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 2 | 2017 | 1143 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2014 | 3474 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39045 | 0.050 |
Why?
|
Point Mutation | 1 | 2005 | 1624 | 0.050 |
Why?
|
POU Domain Factors | 1 | 2020 | 46 | 0.050 |
Why?
|
Neurons, Afferent | 1 | 2002 | 508 | 0.040 |
Why?
|
Synaptophysin | 1 | 2020 | 141 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2020 | 8628 | 0.040 |
Why?
|
Bone Density | 1 | 2012 | 3468 | 0.040 |
Why?
|
Haplotypes | 1 | 2005 | 2781 | 0.040 |
Why?
|
Gastric Mucosa | 1 | 2002 | 599 | 0.040 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2020 | 223 | 0.040 |
Why?
|
Aniline Compounds | 1 | 2023 | 986 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2014 | 21824 | 0.040 |
Why?
|
SOXB1 Transcription Factors | 1 | 2020 | 284 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2022 | 749 | 0.040 |
Why?
|
Hydrostatic Pressure | 1 | 2017 | 106 | 0.040 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 464 | 0.040 |
Why?
|
Epithelium | 1 | 2002 | 1680 | 0.040 |
Why?
|
Asia | 1 | 2018 | 610 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5529 | 0.040 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 504 | 0.040 |
Why?
|
Male | 14 | 2022 | 350027 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 365 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2020 | 10480 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2023 | 1366 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 407 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 496 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20123 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6313 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1265 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2005 | 3420 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2020 | 1731 | 0.030 |
Why?
|
Retrospective Studies | 7 | 2020 | 77426 | 0.030 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2538 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 577 | 0.030 |
Why?
|
DNA Helicases | 1 | 2020 | 861 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2649 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2019 | 726 | 0.030 |
Why?
|
Dogs | 1 | 2019 | 3913 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4567 | 0.030 |
Why?
|
Base Sequence | 3 | 2011 | 12801 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2020 | 987 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
Early Detection of Cancer | 2 | 2018 | 3086 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2023 | 5169 | 0.030 |
Why?
|
Endothelium | 1 | 2016 | 778 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 1114 | 0.030 |
Why?
|
Immunomagnetic Separation | 1 | 2013 | 80 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2133 | 0.030 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2014 | 148 | 0.030 |
Why?
|
Taxoids | 1 | 2017 | 665 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2018 | 708 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2916 | 0.030 |
Why?
|
Cleidocranial Dysplasia | 1 | 2012 | 19 | 0.030 |
Why?
|
Postoperative Care | 1 | 2019 | 1485 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2014 | 17449 | 0.030 |
Why?
|
Mastectomy, Segmental | 1 | 2018 | 956 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1221 | 0.030 |
Why?
|
Color | 1 | 2013 | 307 | 0.030 |
Why?
|
Cell Survival | 2 | 2016 | 5881 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2011 | 18116 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15999 | 0.030 |
Why?
|
Drainage | 1 | 2018 | 1141 | 0.030 |
Why?
|
Receptors, Notch | 1 | 2016 | 739 | 0.030 |
Why?
|
Hot Temperature | 1 | 2017 | 1355 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2848 | 0.030 |
Why?
|
Gene Deletion | 2 | 2014 | 2751 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15294 | 0.020 |
Why?
|
Prostate | 1 | 2020 | 1773 | 0.020 |
Why?
|
Remission Induction | 1 | 2017 | 2389 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2010 | 9735 | 0.020 |
Why?
|
Femoral Neck Fractures | 1 | 2012 | 138 | 0.020 |
Why?
|
Phenobarbital | 1 | 2011 | 192 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2015 | 1097 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15070 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2013 | 345 | 0.020 |
Why?
|
Mice, Knockout | 4 | 2009 | 14556 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 677 | 0.020 |
Why?
|
Mice, Mutant Strains | 2 | 2005 | 1866 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1955 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2422 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2014 | 987 | 0.020 |
Why?
|
Carcinoma, Medullary | 1 | 2010 | 123 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2021 | 3085 | 0.020 |
Why?
|
Receptors, Calcitriol | 1 | 2012 | 350 | 0.020 |
Why?
|
Time Factors | 3 | 2017 | 40063 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2005 | 18027 | 0.020 |
Why?
|
Chondroblastoma | 1 | 2009 | 50 | 0.020 |
Why?
|
Breast | 1 | 2018 | 1969 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1854 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21752 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 1940 | 0.020 |
Why?
|
Thoracoscopy | 1 | 2009 | 178 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9392 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2017 | 2969 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2014 | 1039 | 0.020 |
Why?
|
Medical Oncology | 1 | 2020 | 2265 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3598 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 56436 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3129 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2011 | 12244 | 0.020 |
Why?
|
Image Enhancement | 1 | 2018 | 2921 | 0.020 |
Why?
|
Hypertonic Solutions | 1 | 2007 | 93 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2012 | 1254 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2016 | 2563 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2019 | 2214 | 0.020 |
Why?
|
Radiotherapy | 1 | 2014 | 1525 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4217 | 0.020 |
Why?
|
BRCA2 Protein | 1 | 2011 | 794 | 0.020 |
Why?
|
Ultrasonography | 2 | 2012 | 5982 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3820 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2009 | 498 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 5103 | 0.020 |
Why?
|
Ascites | 1 | 2008 | 344 | 0.020 |
Why?
|
Carcinoma, Lobular | 1 | 2010 | 484 | 0.020 |
Why?
|
Stroke Volume | 1 | 2019 | 5008 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1987 | 0.020 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 198 | 0.020 |
Why?
|
Punctures | 1 | 2007 | 374 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3509 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2016 | 2726 | 0.020 |
Why?
|
Contrast Media | 1 | 2018 | 5300 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2108 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13668 | 0.020 |
Why?
|
Integrin beta3 | 1 | 2005 | 122 | 0.020 |
Why?
|
Rare Diseases | 1 | 2009 | 553 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2938 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9582 | 0.020 |
Why?
|
Length of Stay | 1 | 2018 | 6308 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2009 | 1640 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2009 | 1770 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2005 | 293 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6757 | 0.010 |
Why?
|
Peru | 1 | 2007 | 881 | 0.010 |
Why?
|
Transfection | 1 | 2012 | 5892 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4252 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 9335 | 0.010 |
Why?
|
Radiography, Thoracic | 1 | 2009 | 1265 | 0.010 |
Why?
|
Patient Compliance | 1 | 2013 | 2684 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4841 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 12075 | 0.010 |
Why?
|
Motor Skills Disorders | 1 | 2002 | 90 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2002 | 352 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2003 | 573 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 2875 | 0.010 |
Why?
|
Biopsy, Fine-Needle | 1 | 2007 | 1094 | 0.010 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 651 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2005 | 748 | 0.010 |
Why?
|
Ataxia | 1 | 2003 | 304 | 0.010 |
Why?
|
Ethanol | 1 | 2007 | 1342 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 12718 | 0.010 |
Why?
|
Risk Factors | 2 | 2017 | 72280 | 0.010 |
Why?
|
Insulin | 1 | 2014 | 6583 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2003 | 1547 | 0.010 |
Why?
|
Hyperplasia | 1 | 2002 | 1184 | 0.010 |
Why?
|
Apoptosis | 2 | 2007 | 9728 | 0.010 |
Why?
|
Posture | 1 | 2003 | 958 | 0.010 |
Why?
|
Gene Targeting | 1 | 2002 | 880 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10250 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3461 | 0.010 |
Why?
|
Phenotype | 1 | 2015 | 16365 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7723 | 0.010 |
Why?
|
Stomach | 1 | 2002 | 697 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15525 | 0.010 |
Why?
|
Radiography | 1 | 2008 | 7022 | 0.010 |
Why?
|
Leukocytes | 1 | 2005 | 2040 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2002 | 2726 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9275 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10182 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 1701 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12781 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2439 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 12742 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7879 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 3846 | 0.010 |
Why?
|
Spinal Cord | 1 | 2003 | 1809 | 0.010 |
Why?
|
Aging | 1 | 2013 | 8661 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2002 | 2008 | 0.010 |
Why?
|
Prospective Studies | 1 | 2018 | 53280 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20945 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 35423 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 11732 | 0.010 |
Why?
|
Risk Assessment | 1 | 2009 | 23337 | 0.000 |
Why?
|
Child | 1 | 2016 | 77679 | 0.000 |
Why?
|
Adolescent | 1 | 2016 | 85759 | 0.000 |
Why?
|
Rats | 1 | 2002 | 24273 | 0.000 |
Why?
|